Citigroup »

Crispr Therapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2023-12-31 $7.0M 111k 62.60
2023-09-30 $5.1M 112k 45.39
2023-03-31 $11M 251k 45.23
2022-12-31 $8.3M 205k 40.65
2022-09-30 $14M 207k 65.31
2021-12-31 $2.3M 31k 75.78
2021-03-31 $3.2M 26k 121.81
2020-12-31 $31M 204k 153.15
2020-09-30 $10M 120k 83.60
2020-06-30 $13M 183k 73.45
2020-03-31 $9.7M 229k 42.38
2019-12-31 $9.1M 149k 60.88
2019-09-30 $3.1M 75k 40.90
2019-06-30 $3.7M 79k 47.18
2019-03-31 $1.8M 50k 35.71
2018-12-31 $1.3M 46k 28.67
2018-09-30 $948k 21k 44.32
2018-06-30 $595k 10k 58.79
2018-03-31 $61k 1.3k 46.03
2017-12-31 $30k 1.3k 23.17
2017-09-30 $0 10 0.00
2017-03-31 $2.0k 100 20.00